Palliative treatment of metastatic breast cancer with diethyldioxystilbene diphosphate (Honvan)

Rosset, G.; Barrelet, L.; Alberto, P.

Schweizerische Medizinische Wochenschrift 105(43): 1388-1390

1975


ISSN/ISBN: 0036-7672
PMID: 1215912
Document Number: 89487
21 postmenopausal patients with skin or/and bone metastases of breast carcinoma received 100-120 mg daily diethyldioxystilbene diphosphate (Honvan) orally. 7 objective remissions were observed, 8 tumors remained unchanged, and 6 were progressive. In 3 cases, rapid tumor progression was suggestive of estrogenic stimulation. Side effects were the same as for other estrogens. Diethyldioxystilbene disphosphate is an active estrogenic compound in the treatment of breast carcinoma.

Document emailed within 1 workday
Secure & encrypted payments